12/23
08:42 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/18
09:50 am
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at Truist Financial Corporation from $120.00 to $145.00. They now have a "buy" rating on the stock.
Low
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at Truist Financial Corporation from $120.00 to $145.00. They now have a "buy" rating on the stock.
12/17
10:05 am
gkos
Glaukos (NYSE:GKOS) was given a new $165.00 price target on by analysts at UBS Group AG.
Low
Report
Glaukos (NYSE:GKOS) was given a new $165.00 price target on by analysts at UBS Group AG.
12/17
08:44 am
gkos
Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
12/16
07:00 am
gkos
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
Low
Report
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
12/11
07:20 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/9
10:06 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
11/28
01:15 pm
gkos
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Neutral
Report
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
11/11
01:23 pm
gkos
Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/10
11:06 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/9
01:35 pm
gkos
Should Glaukos' Improved Results and Raised Outlook Prompt a Closer Look From GKOS Investors? [Yahoo! Finance]
Medium
Report
Should Glaukos' Improved Results and Raised Outlook Prompt a Closer Look From GKOS Investors? [Yahoo! Finance]
11/3
07:00 am
gkos
Glaukos Announces Participation in Upcoming Investor Conferences
Low
Report
Glaukos Announces Participation in Upcoming Investor Conferences
10/31
08:08 pm
gkos
Glaukos (GKOS): Losses Deepen, But Revenue Forecasts Challenge Bearish Sentiment [Yahoo! Finance]
Low
Report
Glaukos (GKOS): Losses Deepen, But Revenue Forecasts Challenge Bearish Sentiment [Yahoo! Finance]
10/30
06:43 pm
gkos
Glaukos (GKOS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Glaukos (GKOS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
10/30
05:17 pm
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at JPMorgan Chase & Co. from $110.00 to $120.00. They now have an "overweight" rating on the stock.
Low
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at JPMorgan Chase & Co. from $110.00 to $120.00. They now have an "overweight" rating on the stock.
10/30
12:03 pm
gkos
Glaukos (NYSE:GKOS) was given a new $120.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Glaukos (NYSE:GKOS) was given a new $120.00 price target on by analysts at Truist Financial Corporation.
10/30
10:07 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/30
09:12 am
gkos
Glaukos (NYSE:GKOS) was given a new $122.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
Glaukos (NYSE:GKOS) was given a new $122.00 price target on by analysts at Wells Fargo & Company.
10/30
08:09 am
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at BTIG Research from $104.00 to $116.00. They now have a "buy" rating on the stock.
Medium
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at BTIG Research from $104.00 to $116.00. They now have a "buy" rating on the stock.
10/30
08:09 am
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at Needham & Company LLC from $115.00 to $117.00. They now have a "buy" rating on the stock.
Medium
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at Needham & Company LLC from $115.00 to $117.00. They now have a "buy" rating on the stock.
10/29
04:05 pm
gkos
Glaukos Announces Third Quarter 2025 Financial Results
High
Report
Glaukos Announces Third Quarter 2025 Financial Results
10/27
01:01 pm
gkos
Glaukos (NYSE:GKOS) was given a new $115.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Glaukos (NYSE:GKOS) was given a new $115.00 price target on by analysts at Stifel Nicolaus.
10/26
09:26 am
gkos
Can Glaukos' (GKOS) Latest FDA Approval Reinforce Its Corneal Therapy Leadership? [Yahoo! Finance]
Low
Report
Can Glaukos' (GKOS) Latest FDA Approval Reinforce Its Corneal Therapy Leadership? [Yahoo! Finance]
10/20
08:48 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
10/20
07:00 am
gkos
Glaukos Announces FDA Approval of Epioxa™
Medium
Report
Glaukos Announces FDA Approval of Epioxa™